Michael Diem

Michael Diem

M.D., former Chief Financial OfficeratCentury Therapeutics· In proxies 2022–2023

Pay in FY2023+43% from the year before · Century Therapeutics stock -35.3% the same year

Michael Diem was paid $2.2M in FY2023 (Dec), up 43%. Century Therapeutics stock fell 35.3% that year.

Pay$100 in the stock at the end of FY21 → $21
Pay is from the Summary Compensation Table of each Century Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Century TherapeuticsPublic company · 4 yr
    • M.D., former Chief Financial Officer2022 – Present · 4 yrStock in role -90%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?